These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3919445)

  • 1. Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate.
    Levy RJ; Wolfrum J; Schoen FJ; Hawley MA; Lund SA; Langer R
    Science; 1985 Apr; 228(4696):190-2. PubMed ID: 3919445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats.
    Levy RJ; Hawley MA; Schoen FJ; Lund SA; Liu PY
    Circulation; 1985 Feb; 71(2):349-56. PubMed ID: 3917378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. Experimental studies of optimal dosages and therapeutic durations.
    Levy RJ; Schoen FJ; Lund SA; Smith MS
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):551-7. PubMed ID: 3116348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled-release drug delivery of diphosphonates to inhibit bioprosthetic heart valve calcification: release rate modulation with silicone matrices via drug solubility and membrane coating.
    Golomb G; Dixon M; Smith MS; Schoen FJ; Levy RJ
    J Pharm Sci; 1987 Apr; 76(4):271-6. PubMed ID: 3110404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local controlled-release of diphosphonates from ethylenevinylacetate matrices prevents bioprosthetic heart valve calcification.
    Levy RJ; Golomb G; Wolfrum J; Lund SA; Schoen FJ; Langer R
    Trans Am Soc Artif Intern Organs; 1985; 31():459-63. PubMed ID: 3939275
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic inhibition of the calcification of glutaraldehyde pretreated bovine pericardium in a rat subdermal model by FeCl3 and ethanehydroxydiphosphonate: preincubation and polymeric controlled release studies.
    Hirsch D; Drader J; Pathak YV; Yee R; Schoen FJ; Levy RJ
    Biomaterials; 1993 Jul; 14(9):705-11. PubMed ID: 8399967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local controlled release of 1-hydroxyethylidene diphosphonate using silicone-rubber matrices. Effects of sterilization on in vitro release and in vivo efficacy.
    Johnston TP; Bove EL; Bolling SF; Schoen FJ; Boyd JA; Golomb G; Levy RJ
    ASAIO Trans; 1988; 34(3):835-8. PubMed ID: 3143390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of diphosphonates from synthetic polymers to inhibit calcification.
    Golomb G
    J Biomater Appl; 1987 Oct; 2(2):266-89. PubMed ID: 3144594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of calcification of bioprosthetic heart valve leaflets by Ca2+ diphosphonate pretreatment.
    Johnston TP; Schoen FJ; Levy RJ
    J Pharm Sci; 1988 Sep; 77(9):740-4. PubMed ID: 3147327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of anticalcification treatments on bioprosthetic heart valves implanted in sheep.
    Jones M; Eidbo EE; Hilbert SL; Ferrans VJ; Clark RE
    ASAIO Trans; 1988; 34(4):1027-30. PubMed ID: 3219249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of bioprosthetic heart valve calcification by sustained local delivery of Ca and Na diphosphonate via controlled release matrices.
    Golomb G; Dixon M; Smith MS; Schoen FJ; Levy RJ
    ASAIO Trans; 1986; 32(1):587-90. PubMed ID: 3778777
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism.
    Levy RJ; Vyavahare N; Ogle M; Ashworth P; Bianco R; Schoen FJ
    J Heart Valve Dis; 2003 Mar; 12(2):209-16; discussion 216. PubMed ID: 12701794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups.
    Webb CL; Benedict JJ; Schoen FJ; Linden JA; Levy RJ
    Ann Thorac Surg; 1988 Sep; 46(3):309-16. PubMed ID: 3137904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves.
    Chen W; Schoen FJ; Levy RJ
    Circulation; 1994 Jul; 90(1):323-9. PubMed ID: 8026014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglycidyl amine crosslinking combined with ethanol inhibits bioprosthetic heart valve calcification.
    Connolly JM; Bakay MA; Alferiev IS; Gorman RC; Gorman JH; Kruth HS; Ashworth PE; Kutty JK; Schoen FJ; Bianco RW; Levy RJ
    Ann Thorac Surg; 2011 Sep; 92(3):858-65. PubMed ID: 21871270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticalcification treatments of bioprosthetic heart valves: in vivo studies in sheep.
    Jones M; Eidbo EE; Hilbert SL; Ferrans VJ; Clark RE
    J Card Surg; 1989 Mar; 4(1):69-73. PubMed ID: 2519984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate.
    Rapoport HS; Connolly JM; Fulmer J; Dai N; Murti BH; Gorman RC; Gorman JH; Alferiev I; Levy RJ
    Biomaterials; 2007 Feb; 28(4):690-9. PubMed ID: 17027944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ways to prevent the calcification of heart valve bioprostheses].
    Barbarash LS; Zhuravleva IIu; Medvedeva VM; Shaposhnikov AN
    Biull Eksp Biol Med; 1988 Dec; 106(12):732-4. PubMed ID: 3207883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The No-React anticalcification treatment: a comparison of Biocor No-React II and Toronto SPV stentless bioprostheses implanted in sheep.
    Herijgers P; Ozaki S; Verbeken E; Van Lommel A; Jashari R; Nishida T; Leunens V; Flameng W
    Semin Thorac Cardiovasc Surg; 1999 Oct; 11(4 Suppl 1):171-5. PubMed ID: 10660187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin attenuates bioprosthetic heart valve calcification.
    Lee S; Kim DH; Youn YN; Joo HC; Yoo KJ; Lee SH
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):731-741.e1. PubMed ID: 30738596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.